165 results
Page 6 of 9
8-K
EX-99.1
gseo66rgdxw 3q34g
5 Mar 15
Prothena Reports Fourth Quarter and Full Year 2014 Financial Results and Provides 2015 Financial Guidance and R&D Update
12:00am
8-K
EX-99.1
8dcuzc40crn sb8o
15 Dec 14
Prothena Receives FDA Fast Track Designation for NEOD001, a Monoclonal Antibody for the Treatment of Patients with AL Amyloidosis
12:00am
8-K
EX-99.1
ixyza1 xet
2 Dec 14
Other Events
12:00am
8-K
EX-99.1
5sd450otl0yf
3 Nov 14
Prothena Reports Third Quarter 2014 Financial Results and R&D Progress
12:00am
8-K
EX-99.1
tonkcw6f77golfln8
4 Aug 14
Prothena Reports Second Quarter 2014 Financial Results and R&D Progress
12:00am
424B5
wb3bt
25 Jun 14
Prospectus supplement for primary offering
12:00am
424B5
37h8cte
23 Jun 14
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
kg7loo z8unh00pmxg80
6 Mar 14
Prothena Reports Fourth Quarter and Full Year 2013 Financial Results and Provides Research and Development Update
12:00am
8-K
74dxpinxu22scgoc4
6 Mar 14
Prothena Reports Fourth Quarter and Full Year 2013 Financial Results and Provides Research and Development Update
12:00am
424B3
iaxcjflit5pz8ojjgb
29 Jan 14
Prospectus supplement
12:00am
424B3
o2fdfbgb
27 Jan 14
Prospectus supplement
12:00am